Shital Vekeria
About Shital Vekeria
Shital Vekeria is a Senior Disease Area Specialist in Oncology at Bristol Myers Squibb with extensive experience in clinical pharmacology and oncology, having previously held various roles in the NHS and contributed to medical strategies for cancer treatment.
Company
Shital Vekeria currently works at Bristol Myers Squibb as a Senior Disease Area Specialist Oncology. This role involves developing and implementing medical strategies for cancer treatment, leveraging her extensive experience in oncology and clinical pharmacology.
Title
Shital Vekeria holds the title of Senior Disease Area Specialist Oncology. In this capacity, she focuses on optimizing oncology drug therapy, bridging the gap between clinical research and patient care, and ensuring compliance with medical regulations.
Education and Expertise
Shital Vekeria earned her Master of Pharmacy (MPharm) from the School of Pharmacy, University of London, from 2003 to 2007. She also completed her A Levels at Woodhouse College. Vekeria has extensive experience in oncology, clinical pharmacology, and regulatory affairs, making significant contributions to cancer treatment strategies.
Background
Shital Vekeria's professional background includes various roles at prominent healthcare institutions. She served as a Final Medical Signatory and Medical Science Manager at Bristol Myers Squibb, Specialist HIV Pharmacist and Resident Pharmacist at Chelsea and Westminster Hospital NHS Foundation Trust, Pharmacist at Royal National Orthopaedic Hospital NHS Trust, and Pre-registration Pharmacist at The Hillingdon Hospitals NHS Foundation Trust.
Achievements
Shital Vekeria has contributed to the publication of research papers in oncology and clinical pharmacology. She actively participates in both professional development and community outreach programs, mentoring junior pharmacists and medical professionals, and raising awareness about cancer prevention and treatment. Her expertise in regulatory affairs helps ensure compliance with pharmaceutical regulations, supporting the development and implementation of effective medical strategies.